Background: Though peritoneal dialysis has several limitations, it is still used in acute kidney injury (AKI) patients as an alternative method of Renal Replacement Therapy (RRT), especially in low socioeconomic countries. Materials and Method: This study included thirty patients diagnosed as AKI. Peritoneal access was established through flexible Tenckhoff catheter for Continuous Peritoneal Dialysis (CPD) and 6-8 exchanges were done in 24 hours. Results: Among 30 patients mean age was (mean±SD) 49.93±14.42 years. Seven (23.33%) patients were hemodynamically unstable. The cause of AKI was drug induced in 6(20.7%), hypovolemia/Acute Tubular Necrosis in 6(20.0%), sepsis in 5(16.7%), heart failure in 2(6.7%) and 11(36.7%) had multiple causes. In initial presentation, mean serum creatinine was 683.42 μmol/L, and the number of sessions required for stabilization of serum creatinine was 7.5±1.43, sessions required for correction of hyperkalemia and metabolic acidosis were 2.15±0.69 and 2.5±0.76 respectively. The delivered Kt/V urea was 1.95±0.14 weekly. Six (20.0%) patients had peritonitis, five (16.7%) had pericatheter leakage and four (13.33%) had catheter blockage. Among 30 patients, three patients (10%) had died, sixteen (59.3%) had recovery of renal function and rest did not recover renal function. Conclusion: CPD was effective for correction of metabolic and electrolyte imbalance.
INTRODUCTION:
Acute kidney injury (AKI) is a syndrome characterized by a sudden deterioration in renal function over several hours to several weeks. AKI requiring Renal Replacement Therapy (RRT) occurs in approximately 1% to 2% of hospitalized patients and in 6% to 7% of critically ill patients 1 . Severe or life threatening AKI demands a form of renal replacement therapy (RRT) that is initiated to return the parameters of the body's internal milieu to normal. Continuous peritoneal dialysis (CPD) has many potential advantages. It is technically simple with minimal infrastructure requirements. Here solute removal is gradual with less potential risk for disequilibrium syndrome. Since no extracorporeal circulation is required, there is relatively good hemodynamic tolerance and residual renal function all may be better preserved. So interest in using CPD to manage AKI patients has been increasing. Continuous peritoneal dialysis and daily hemodialysis both are effective for treating AKI patients and are similar with regard to survival rate, recovery of kidney function and metabolic control 2 . The objective of this study was to assess the effectiveness of CPD as a form of renal replacement therapy in AKI and to observe the outcome and mechanical complications.
MATERIALS AND METHODS:
This was an observational study carried out in the Department of Nephrology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh from January 2015 to September 2016.Patients with clinical and laboratory criteria of AKI {According to Acute Kidney Injury Network (AKIN) criteria} and had indication for RRT were included in this study. Indications for commencing dialysis were symptomatic uremia, hyperkalemia (serum potassium > 6.5 mmol/l), severe metabolic acidosis (pH <7.15), fluid overload, oliguria (urine output <0.3 ml/kg for 24 hours). Patients unwilling to give consent, age below 18 years, chronic kidney disease (CKD) stage 4 and 5, urinary tract obstruction, pregnancy, recent abdominal surgery (< 1 month), prerenal AKI, rapidly progressive glomerulonephritis (RPGN) were excluded. After evaluation by history, physical examination and laboratory investigations, patients who were diagnosed as AKI and had indication of RRT (as mentioned previously) were included. Effectiveness of peritoneal dialysis was determined by formula for Kt/V, where K = dialyzer clearance of urea, t = duration of dialysis, V = volume of distribution of urea. At the beginning of each dialysis session serum creatinine; serum electrolytes and ABG analysis were done. Dialysate fluid (10 ml) was taken for measurement of urea from each bag. When peritonitis was suspected dialysate fluid was taken and sent for cytology and culture sensitivity. CPD was discontinued temporarily for spacing or observation in case of Partial recovery or stabilization of renal function as defined below:
-Restoration of diuresis (gradually increase to more than 1000 mL urine in 24 hours), -A progressive fall in serum creatinine (<353 μmol/L), -Change of dialysis method (i.e. hemodialysis), -The death of the patient, -Absence of recovery of renal functions after 30 days. Patients with no recovery of renal function were kept on dialysis and those with stabilized renal function were followed up for at least two weeks before removal of Tenckhoff catheter. At the time of discharge they were advised to come for follow-up at the end of 1 st , 2 nd and 3 rd month and at each visit they were assessed for recovery of renal function. Finally, the patients were labeled as renal recovery or no recovery. Recovery of renal function was defined as: Serum creatinine level less than 1.3mg/dl Serum Urea level less than 40 mg/ dl Serum sodium level 135-145mmol/L Serum potassium level between 3.5-4.5mmol/L and Urine output more than 0.5ml/kg/hr The result was presented as mean+SD or median, according to normality characteristics of each variable with 5% (p<0.05) significance level. To compare parametric variables paired t-test was used. Data was analyzed using Statistical Package for Social Science (SPSS) v 22.0 (Chicago, IL) software. Table 1 shows the basic characteristic of the patients at the time of enrolment. Mean age of the patients was 49.93 years. Male was 66.7% and female 33.3%. Weight was 62.4±4.61 kg (mean±SD). Mean SBP was 112.0 mm Hg and DBP 64.8 mm Hg. Seven patients were hemodynamically unstable. Mean urine volume was 383.6 ml in 24 hours. The cause of AKI was drug induced in 6(20.0%) patients, hypovolemia/Acute Tubular Necrosis (ATN) in 6(20.0%) patients, sepsis in 5(16.67%) patients, heart failure in 2(6.7%) patients and 11(36.7%) had multiple causes. The co-morbidities were as follows: 11(36.7%) patients had Diabetes Mellitus, 9(30%) Hypertension, 9(30%) Chronic Kidney Disease, 9(30%) Ischemic Heart Disease and 3(10%) patients had cerebrovascular disease. Majority of the patients had uremic symptoms 26(86.7%), followed by in descending order oliguria 14(46.7%), hyperkalemia (>6.5 mmol/L) 13(43.3%), fluid overload 7(23.3%) and metabolic acidosis 8(26.7%) cases. Table 2 shows outcomes of CPD in AKI patients and 13 on 150 AKI patients who had undergone CPD showed that 57.3% died, 23% recovered renal function and 6.6% remain on dialysis on hospital discharge. Compared to this study mortality rate was lower in our study. As this was a single center study done in a short period of time, all the results were not consistent with similar studies. Considering the limitations of this study, it may be recommended that further large scale multi center randomized controlled trials of larger duration including comparison of continuous ambulatory peritoneal dialysis with different other modalities of renal replacement therapy may be done in AKI patients.
RESULTS:

CONCLUSION:
Continuous peritoneal dialysis was effective in correction of metabolic and electrolyte imbalance. Adequate and gradual reduction of serum creatinine and urea within an acceptable time span could be achieved with favorable outcome and minimal complications. Thus it can be used as an alternative to other form of RRT in AKI.
